The ASH Research Collaborative (ASH RC) is a non-profit organization that was established by the American Society of Hematology (ASH) in 2018 to foster collaborative partnerships to accelerate progress in hematology, with the goal of improving the lives of people affected by blood diseases.
The foundation of the ARC is its Registry, a technology platform that facilitates the exchange of information by aggregating in one place, and making available for inquiry, research-grade data on hematologic diseases. The first research initiative of ARC is a Sickle Cell Disease (SCD) Clinical Trials Network (CTN), which will launch in 2019 to optimize the conduct of clinical trials research in SCD. The Network will leverage the Registry to collect key information and identify gaps that will help advance SCD research and treatment.
Fill out this form to join our mission and help us make a difference in the SCD community.